Michael Greenwood

Michael Greenwood

Feature Writer

B.Sc. Chemistry, M.Sc. Drug Design and Discovery

Michael graduated from the University of Salford with a PhD in Biochemistry in 2023, and has keen research interests towards nanotechnology and its application to biological systems. Michael has written on a wide range of science communication and news topics within the life sciences and related fields since 2019, and engages extensively with current developments in journal publications.  

Articles from Michael

SARS-CoV-2 B.1.1.7 and B.1.351 variants exhibit enhanced affinity towards the ACE2 receptor

SARS-CoV-2 B.1.1.7 and B.1.351 variants exhibit enhanced affinity towards the ACE2 receptor

SARS-CoV-2 virus persistence in immunocompromised individuals

SARS-CoV-2 virus persistence in immunocompromised individuals

History of Microbiology – Germ Theory and Immunity

History of Microbiology – Germ Theory and Immunity

Nanopore analysis identifies pseudouridine modifications in SARS-CoV-2

Nanopore analysis identifies pseudouridine modifications in SARS-CoV-2

Is COVID-19 a new disease?

Is COVID-19 a new disease?

SARS-CoV-2 is activated for fusion by a broad range of proteases, finds study

SARS-CoV-2 is activated for fusion by a broad range of proteases, finds study

Monocytes promote viral control during SARS-COV-2 infection

Monocytes promote viral control during SARS-COV-2 infection

Stem cell therapy for COVID-19 and ARDS

Stem cell therapy for COVID-19 and ARDS

Rapid and sensitive SARS-CoV-2 detection from saliva using CRISPR

Rapid and sensitive SARS-CoV-2 detection from saliva using CRISPR

SARS-CoV-2 study in human gut organoids

SARS-CoV-2 study in human gut organoids

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.